BCL6 is reportedly upregulated in glioblastoma and gastric, ovarian, and non-small cell lung cancers, and its expression is associated with malignant features, including proliferation, invasivity, migratory activity, survival, and therapeutic resistance (55). The gene discussed is BCL6; the disease is glioblastoma.